🇺🇸 FDA
Pipeline program

Follicle Stimulating Hormone Receptor T Cells

MCC-21113

Phase 1 small_molecule active

Quick answer

Follicle Stimulating Hormone Receptor T Cells for Ovarian Cancer is a Phase 1 program (small_molecule) at Anixa Biosciences Inc with 1 ClinicalTrials.gov record(s).

Program details

Company
Anixa Biosciences Inc
Indication
Ovarian Cancer
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials